[1]
|
Ray, A.K., Somanchi, S.S., Dastgheyb, N., et al. (2019) Expression of Carcinoma, Apoptosis, and Cell-Death-Related Genes Are Determinants for Sensitivity of Pediatric Cancer Cell Lines to Lysis by Natural Killer Cells. Pediatric Blood & Cancer, 66, 27783. https://doi.org/10.1002/pbc.27783
|
[2]
|
杨志刚, 曾耀英, 何贤辉君, 等. 一种分离、培养扩增小鼠NK细胞方法的建立[J]. 细胞与分子免疫学杂志, 2005, 21(3): 379-389.
|
[3]
|
Behzadi, P., Behzadi, E. and Ranjbar, R. (2016) IL-12 Family Cytokines: General Characteristics, Pathogenic Microorganisms, Receptors, and Signal-ling Pathways. Acta Microbiologica et Immunologica Hungarica, 63, 1-25.
https://doi.org/10.1556/030.63.2016.1.1
|
[4]
|
Fensome, A., Ambler, C.M., Arnoid, E., et al. (2020) Design and Optimization of a Series of 4-(3-azabic-yclo[3.1.0] hexan-3-yl)pyrimidin-2-amines: Dual Inhibitors of TYK2 and JAK1. Bioorganic Medicinal Chemistry, 28, 115481- 115502. https://doi.org/10.1016/j.bmc.2020.115481
|
[5]
|
Swain, M.G. (2010) Natural Killer T Cells within the Liver: Conductors of the Hepatic Immune Orchestra. Digestive Diseases (Basel, Switzerland), 28, 7-13. https://doi.org/10.1159/000282059
|
[6]
|
Madera, S. and Sun, J.C. (2015) Cutting Edge: Stage-Specific Requirement of IL-18 for Antiviral NK Cell Expansion. Journal of Immunology, 194, 1408-1412. https://doi.org/10.4049/jimmunol.1402001
|
[7]
|
Sharma, R. and Das, A. (2018) IL-2 Mediates NK Cell Prolifera-tion but Not Hyperactivity. Immunologic Research, 66, 151-157. https://doi.org/10.1007/s12026-017-8982-3
|
[8]
|
Tait Wojno, E.D., Hunter, C.A. and Stumhofer, J.S. (2019) The Immunobiology of the Interleukin-12 Family: Room for Discovery. Immunity, 50, 851-870. https://doi.org/10.1016/j.immuni.2019.03.011
|
[9]
|
Törnroos, H., Hägerstrand, H. and Lindqvist, C. (2019) Cultur-ing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15—Implications for Clinical Trials. Anti-cancer Research, 39, 107-112.
https://doi.org/10.21873/anticanres.13085
|
[10]
|
朱向情, 刘凌, 吴琼, 等. 自然杀伤细胞分离、培养方法的建立[J]. 中华细胞与干细胞杂志(电子版), 2021, 2(4): 269-273. https://navi.cnki.net/knavi/journals/ZXGA/detail?uniplatform=NZKPT
|
[11]
|
Abel, A.M., Yang, C., Thakar, M.S., et al. (2018) Natural Killer Cells: Development, Maturation, and Clinical Utilization. Frontiers in Immunology, 9, 1869. https://doi.org/10.3389/fimmu.2018.01869
|
[12]
|
Zhang, M.L., Wen, B., Aaton, O.M., et al. (2018) IL-15 Enhanced Antibody-Dependent Cellular Cytotoxicity Mediated by NK Cells and Macrophages. Proceedings of the National Acad-emy of Sciences of the United States of America, 115, 10915-10924. https://doi.org/10.1073/pnas.1811615115
|
[13]
|
Arachchige, A.S.P.M. (2021) Human NK Cells: From Development to Effector Functions. Innate Immunity, 27, 212- 229.
|
[14]
|
Montazersaheb, S., Fathi, E. and Farahzadi, R. (2021) Cyto-kines and Signaling Pathways Involved in Differentiation Potential of Hematopoietic Stem Cells towards Natural Killer Cells. Tissue & Cell, 70, Article ID: 101501.
https://doi.org/10.1016/j.tice.2021.101501
|
[15]
|
Waldmann, T.A., Lugli, E., Roederer, M., et al. (2011) Safety (Toxicity), Pharmacokinetics, Immunogenicity, and Impact on Elements of the Normal Immune System of Recombinant Human IL-15 Inrhesus Macaques. Blood, 117, 4787- 4795. https://doi.org/10.1182/blood-2010-10-311456
|
[16]
|
Dam, M.M.O., Prins, H.J., Boerwan, G.H., et al. (2016) Preparation of Cytokine-Activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic Potential. Immunotherapy, 39, 90-100.
https://doi.org/10.1097/CJI.0000000000000110
|
[17]
|
Marcaiis, A., Viel, S., Grau, M., et al. (2013) Regulation of Mouse NK Cell Development and Function by Cytokines. Frontiers in Immunology, 4, 450. https://doi.org/10.3389/fimmu.2013.00450
|
[18]
|
Choi, Y.H., Lim, E.J., Kim, S.W., et al. (2019) IL-27 Enhances IL-15/IL-18-Mediated Activation of Human Natural Killer Cells. The Journal for ImmunoTherapy of Cancer, 7, 168. https://doi.org/10.1186/s40425-019-0652-7
|
[19]
|
Vecchié, A., Bonaventura, A., Toldo, S., et al. (2021) IL-18 and Infections: Is There a Role for Targeted Therapies? Journal of Cellular Physiology, 236, 1638-1657. https://doi.org/10.1002/jcp.30008
|
[20]
|
Kaplanski, G. (2018) Interleukin-18: Biological Properties and Role in Dis-ease Pathogenesis. Immunological Reviews, 281, 138-153. https://doi.org/10.1111/imr.12616
|
[21]
|
Sherratt, S., Pa-tel, A., Baker, D.A., et al. (2020) Affiliations Differential IL-18 Dependence of Canonical and Adaptive NK Cells for Antibody Dependent Responses to P. falciparum. Frontiers in Immunology, 11, 533.
https://doi.org/10.3389/fimmu.2020.00533
|
[22]
|
Wawrocki, S., Druszczynska, M., Kowalewicz, K.M., et al. (2016) Interleukin 18 (IL-18) as a Target for Immune Intervention. Acta Biochimica Polonica, 63, 59-63. https://doi.org/10.18388/abp.2015_1153
|
[23]
|
Jakobisiak, M., Golab, J., Lasek, W., et al. (2011) Interleukin 15 as a Promising Candidate for Tumor Immunotherapy. Cytokine and Growth Factor Reviews, 22, 99-108. https://doi.org/10.1016/j.cytogfr.2011.04.001
|
[24]
|
Kweon, S.H., Phan, M.T.T., Chun, S., et al. (2019) Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21. Frontiers in Immunology, 10, 879.
https://doi.org/10.3389/fimmu.2019.00879
|
[25]
|
Harper, J., Huot, N., Micci, L., et al. (2021) IL-21 and IFNα Therapy Rescues Terminally Differentiated NK Cells and Limits SIV Reservoir in ART-Treated Macaques. Nature Communications, 12, 2866.
https://doi.org/10.1038/s41467-021-23189-7
|
[26]
|
Toomey, J.A., Gays, F., Foster, D., et al. (2015) Extending the Lifespan and Efficacies of Immune Cells Used in Adoptive Transfer for Cancer Immunotherapies—A Review. Oncoim-munology, 4, e1002720.
https://doi.org/10.1080/2162402X.2014.1002720
|
[27]
|
Mcmichael, E.L., Jaime-Ramirez, A.C., Guenterberg, K.D., et al. (2017) IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells. Clinical Cancer Research, 23, 489-502.
https://doi.org/10.1158/1078-0432.CCR-16-0004
|
[28]
|
Brady, J., Carotta, S., Thong, R.P.L., et al. (2010) The In-teractions of Multiple Cytokines Control NK Cell Maturation. Immunology, 185, 6679-6688. https://doi.org/10.4049/jimmunol.0903354
|
[29]
|
Allison, M., Mathews, J., Gilliland, T., et al. (2022) Natural Killer Cell-Mediated Immunotherapy for Leukemia. Cancer (Basel), 14, 843. https://doi.org/10.3390/cancers14030843
|
[30]
|
Kaweme, N.M. and Zhou, F.L. (2021) Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment. Frontiers in Immunology, 12, Article ID: 683381.
https://doi.org/10.3389/fimmu.2021.683381
|
[31]
|
王晓梦, 李玲, 于津浦, 等. 四种NK细胞体外扩增方案的比较[J]. 中国肿瘤生物治疗杂志, 2013, 20(3): 336-341.
|
[32]
|
张彩, 田志刚. 人NK细胞克隆化培养条件的初步探讨[J]. 中国肿瘤生物治疗杂志, 1999, 6(3): 181-182.
|
[33]
|
Uppendahl, L.D., Felices, M., Bendzick, L., et al. (2019) Cy-tokine-Induced Memory-Like Natural Killer Cells Have Enhanced Function, Proliferation, and in Vivo Expansion against Ovarian Cancer Cells. Gynecologic Oncology, 153, 149-157. https://doi.org/10.1016/j.ygyno.2019.01.006
|
[34]
|
Terrén, I., Mikelez, I., Odriozola, I., et al. (2018) Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cyto-kine-Preactivated Natural Killer Cells. Frontiers in Immunology, 9, 737. https://doi.org/10.3389/fimmu.2018.00737
|
[35]
|
Choi, I., Yoon, S.R., Park, S.Y., et al. (2014) Donor-Derived Nat-ural Killer Cells Infused after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study. Biology of Blood and Marrow Transplantation, 20, 696-704. https://doi.org/10.1016/j.bbmt.2014.01.031
|
[36]
|
Goel, G., Tye-Din, J.A., Qiao, S.W., et al. (2019) Cytokine Re-lease and Gastrointestinal Symptoms after Gluten Challenge in Celiac Disease. Clinical Trial, 5, eaaw7756. https://doi.org/10.1126/sciadv.aaw7756
|
[37]
|
张彦, 王志华, 张春艳, 等. 无血清培养基与完全培养基对体外激活的A-NK细胞支持作用的比较[J]. 中国肿瘤生物治疗杂志, 2003, 10(1): 38.
|
[38]
|
Luevano, M., Domogala, A., Blundell, M., et al. (2014) Frozen Cord Blood Hematopoietic Stem Cells Differentiate into Higher Numbers of Function-al Natural Killer Cells in Vitro than Mobilized Hematopoietic Stem Cells or Freshly Isolated Cord Blood Hematopoietic Stem Cells. PLOS ONE, 9, e87086. https://doi.org/10.1371/journal.pone.0087086
|
[39]
|
Rogatko, K.M., Mika, W.R., Bogunia, K.K., et al. (2016) Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 64, 63-71.
https://doi.org/10.1007/s00005-016-0438-2
|
[40]
|
Anna, D., Michael, B., Adrian, T., et al. (2017) Natural Killer Cells Differentiated in Vitro from Cord Blood CD34+ Cells Are More Advantageous for Use as an Immunotherapy than Peripheral Blood and Cord Blood Natural Killer Cells. Cytotherapy, 19, 710-720. https://doi.org/10.1016/j.jcyt.2017.03.068
|
[41]
|
David, D.F., Khusraw, J., Maria, J.P., et al. (2022) Natural Killer Cells Kill Extracellular Pseudomonas aeruginosa Using Contact-Dependent Release of Granzymes B and H. PLOS Pathogens, 18, e1010325.
https://doi.org/10.1371/journal.ppat.1010325
|
[42]
|
陈玲, 吕小婷, 徐涛, 等. 3种不同抗凝剂对外周血培养的NK细胞功能影响[J]. 生物医学工程与临床, 2018, 22(5): 572-577.
|